SEC Comment Letter for Immatics N.V. (IMTX, IMTXW) (CIK 0001809196) (IMTX) — Aug 6, 2021
Immatics N.V. (IMTX, IMTXW) (CIK 0001809196)
Date: Aug. 6, 2021 · CIK: 0001809196 · Accession: 0000000000-21-009660
AI Filing Summary & Sentiment
File numbers found in text: 333-258351
Letter
United States securities and exchange commission logo August 6, 2021 Harpreet Singh Chief Executive Officer and Director Immatics N.V. Paul-Ehrlich-Straße 15 72076 Tübingen, Federal Republic of Germany Re:Immatics N.V. Registration Statement on Form F-3 Filed August 2, 2021 File No. 333-258351 Dear Dr. Singh: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Margaret Schwartz at 202-551-7153 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: David Li, Esq.
Show Raw Text
United States securities and exchange commission logo
August 6, 2021
Harpreet Singh
Chief Executive Officer and Director
Immatics N.V.
Paul-Ehrlich-Straße 15
72076 Tübingen, Federal Republic of Germany
Re:Immatics N.V.
Registration Statement on Form F-3
Filed August 2, 2021
File No. 333-258351
Dear Dr. Singh:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Margaret Schwartz at 202-551-7153 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: David Li, Esq.